Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_assertion type Assertion NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_head.
- NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_assertion description "[Approximately 10-20% of BC is represented by triple negative breast cancer (TNBC) which is aggressive, the prognosis is poor and patients cannot benefit from targeted treatment based on hormonal or HER2 receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_provenance.
- NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_assertion evidence source_evidence_literature NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_provenance.
- NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_assertion SIO_000772 25374001 NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_provenance.
- NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_assertion wasDerivedFrom befree-2016 NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_provenance.
- NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_assertion wasGeneratedBy ECO_0000203 NP1235364.RA1KmltRr4sJi-kB3J9kj7eQhOJri31_j41KMK_UvWCb4130_provenance.